{"count": 86, "results": [{"_id": "32416710", "pmid": 32416710, "title": "Combination of Naringenin and Lisinopril Ameliorates Nephropathy in Type-1 Diabetic Rats.", "journal": "Endocr Metab Immune Disord Drug Targets", "authors": ["Kulkarni YA", "Suryavanshi SV"], "date": "2021-01-01T00:00:00Z", "doi": "10.2174/1871530320666200516163919", "meta_date_publication": "2021", "meta_volume": "21", "meta_issue": "1", "meta_pages": "173-182", "score": 50266.707, "text_hl": "Combination of @CHEMICAL_naringenin @CHEMICAL_MESH:C005273 @@@Naringenin@@@ and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ Ameliorates @<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@Nephropathy@@@ in @DISEASE_Diabetes_Mellitus_Type_1 @DISEASE_MESH:D003922 @@@Type-1 Diabetic@@@ @SPECIES_10116 @@@Rats@@@.", "citations": {"NLM": "Kulkarni YA, Suryavanshi SV. Combination of Naringenin and Lisinopril Ameliorates Nephropathy in Type-1 Diabetic Rats. Endocr Metab Immune Disord Drug Targets. 2021;21(1):173-182. PMID: 32416710", "BibTeX": "@article{32416710, title={Combination of Naringenin and Lisinopril Ameliorates Nephropathy in Type-1 Diabetic Rats.}, author={Kulkarni YA and Suryavanshi SV}, journal={Endocr Metab Immune Disord Drug Targets}, volume={21}, number={1}, pages={173-182}}"}}, {"_id": "34975523", "pmid": 34975523, "pmcid": "PMC8719629", "title": "Treatment With Lisinopril Prevents the Early Progression of Glomerular Injury in Obese Dahl Salt-Sensitive Rats Independent of Lowering Arterial Pressure", "journal": "Front Physiol", "authors": ["Brown AK", "Nichols A", "Coley CA", "Ekperikpe US", "McPherson KC", "Shields CA", "Poudel B", "Cornelius DC", "Williams JM"], "date": "2021-12-17T00:00:00Z", "doi": "10.3389/fphys.2021.765305", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "765305", "score": 50259.98, "text_hl": "...Effects of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ on the Early Progression of @<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@Renal Injury@@@ in SS and SSLepRmutant Rats", "citations": {"NLM": "Brown AK, Nichols A, Coley CA, Ekperikpe US, McPherson KC, Shields CA, Poudel B, Cornelius DC, Williams JM. Treatment With Lisinopril Prevents the Early Progression of Glomerular Injury in Obese Dahl Salt-Sensitive Rats Independent of Lowering Arterial Pressure Front Physiol. 2021;12():765305. PMID: 34975523", "BibTeX": "@article{34975523, title={Treatment With Lisinopril Prevents the Early Progression of Glomerular Injury in Obese Dahl Salt-Sensitive Rats Independent of Lowering Arterial Pressure}, author={Brown AK and Nichols A and Coley CA and Ekperikpe US and McPherson KC and Shields CA and Poudel B and Cornelius DC and Williams JM}, journal={Front Physiol}, volume={12}, pages={765305}}"}}, {"_id": "34282598", "pmid": 34282598, "title": "Effect of Lisinopril and Verapamil on Angiopoietin 2 and Endostatin in Hypertensive Diabetic Patients with Nephropathy: A Randomized Trial.", "journal": "Horm Metab Res", "authors": ["Salem M", "Sallam AM", "Abdel-Aleem E", "El-Mesallamy HO"], "date": "2021-07-01T00:00:00Z", "doi": "10.1055/a-1517-6643", "meta_date_publication": "2021 Jul", "meta_volume": "53", "meta_issue": "7", "meta_pages": "470-477", "score": 50255.984, "text_hl": "Effect of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ and @CHEMICAL_Verapamil @CHEMICAL_MESH:D014700 @@@Verapamil@@@ on @GENE_ANGPT2 @GENE_285 @@@Angiopoietin 2@@@ and @GENE_COL18A1 @GENE_80781 @@@Endostatin@@@ in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@Hypertensive Diabetic@@@ @SPECIES_9606 @@@Patients@@@ with @<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@Nephropathy@@@: A Randomized Trial.", "citations": {"NLM": "Salem M, Sallam AM, Abdel-Aleem E, El-Mesallamy HO. Effect of Lisinopril and Verapamil on Angiopoietin 2 and Endostatin in Hypertensive Diabetic Patients with Nephropathy: A Randomized Trial. Horm Metab Res. 2021 Jul;53(7):470-477. PMID: 34282598", "BibTeX": "@article{34282598, title={Effect of Lisinopril and Verapamil on Angiopoietin 2 and Endostatin in Hypertensive Diabetic Patients with Nephropathy: A Randomized Trial.}, author={Salem M and Sallam AM and Abdel-Aleem E and El-Mesallamy HO}, journal={Horm Metab Res}, volume={53}, number={7}, pages={470-477}}"}}, {"_id": "35656292", "pmid": 35656292, "pmcid": "PMC9152216", "title": "Potential Role of Lisinopril in Reducing Atherosclerotic Risk: Evidence of an Antioxidant Effect in Human Cardiomyocytes Cell Line", "journal": "Front Pharmacol", "authors": ["Scisciola L", "Fontanella RA", "Surina", "Garofalo G", "Rizzo MR", "Paolisso G", "Barbieri M"], "date": "2022-05-17T00:00:00Z", "doi": "10.3389/fphar.2022.868365", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "868365", "score": 50251.977, "text_hl": "Recently, it has been shown that @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ can attenuate @<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@renal oxidative injury@@@ in the @CHEMICAL_NG_Nitroarginine_Methyl_Ester @CHEMICAL_MESH:D019331 @@@l-NAME@@@-induced @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_10116 @@@rat@@@ and cause an impressive improvement in the antioxidant defense system of Wistar @SPECIES_10116 @@@rats@@@ treated with @CHEMICAL_Doxorubicin @CHEMICAL_MESH:D004317 @@@doxorubicin@@@. ", "citations": {"NLM": "Scisciola L, Fontanella RA, Surina, Garofalo G, Rizzo MR, Paolisso G, Barbieri M. Potential Role of Lisinopril in Reducing Atherosclerotic Risk: Evidence of an Antioxidant Effect in Human Cardiomyocytes Cell Line Front Pharmacol. 2022;13():868365. PMID: 35656292", "BibTeX": "@article{35656292, title={Potential Role of Lisinopril in Reducing Atherosclerotic Risk: Evidence of an Antioxidant Effect in Human Cardiomyocytes Cell Line}, author={Scisciola L and Fontanella RA and Surina and Garofalo G and Rizzo MR and Paolisso G and Barbieri M}, journal={Front Pharmacol}, volume={13}, pages={868365}}"}}, {"_id": "35767209", "pmid": 35767209, "title": "Renoprotective effects of empagliflozin in type 1 and type 2 models of diabetic nephropathy superimposed with hypertension.", "journal": "Geroscience", "authors": ["Williams JM", "Murphy SR", "Wu W", "Border JJ", "Fan F", "Roman RJ"], "date": "2022-12-01T00:00:00Z", "doi": "10.1007/s11357-022-00610-7", "meta_date_publication": "2022 Dec", "meta_volume": "44", "meta_issue": "6", "meta_pages": "2845-2861", "score": 50251.83, "text_hl": "The present study examined if controlling @DISEASE_Hyperglycemia @DISEASE_MESH:D006943 @@@hyperglycemia@@@ with @CHEMICAL_empagliflozin @CHEMICAL_MESH:C570240 @@@empagliflozin@@@, or given in combination with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, slows the progression of @<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@renal injury@@@ in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive diabetic@@@ @SPECIES_10116 @@@rats@@@. ", "citations": {"NLM": "Williams JM, Murphy SR, Wu W, Border JJ, Fan F, Roman RJ. Renoprotective effects of empagliflozin in type 1 and type 2 models of diabetic nephropathy superimposed with hypertension. Geroscience. 2022 Dec;44(6):2845-2861. PMID: 35767209", "BibTeX": "@article{35767209, title={Renoprotective effects of empagliflozin in type 1 and type 2 models of diabetic nephropathy superimposed with hypertension.}, author={Williams JM and Murphy SR and Wu W and Border JJ and Fan F and Roman RJ}, journal={Geroscience}, volume={44}, number={6}, pages={2845-2861}}"}}, {"_id": "37303355", "pmid": 37303355, "pmcid": "PMC10257359", "title": "Chronic Kidney Disease of Non-traditional Etiology in a Young Man From Central America: Geography, Poverty, and Uncertain Pathophysiology Create a Formidable Medical Challenge", "journal": "Cureus", "authors": ["Milki AA", "Bechara M", "Lew SQ", "Poon AN"], "date": "2023-05-11T00:00:00Z", "doi": "10.7759/cureus.38876", "meta_date_publication": "2023 May", "meta_volume": "15", "meta_issue": "5", "meta_pages": "e38876", "score": 50244.67, "text_hl": "Although @DISEASE_Glomerulosclerosis_Focal_Segmental @DISEASE_MESH:D005923 @@@FSGS@@@ would be a rare manifestation, the @SPECIES_9606 @@@patient@@@'s risk factors strongly suggested @DISEASE_Renal_Insufficiency_Chronic @DISEASE_MESH:D051436 @@@chronic kidney disease of unknown@@@ etiology (CKDu) - also known as @DISEASE_Chronic_Kidney_Diseases_of_Uncertain_Etiology @DISEASE_MESH:D000092702 @@@Mesoamerican nephropathy@@@ (@DISEASE_Chronic_Kidney_Diseases_of_Uncertain_Etiology @DISEASE_MESH:D000092702 @@@MeN@@@) - a phenomenon he had never previously heard of. He took @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ for the last six years to manage his @<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@kidney disease@@@. ", "citations": {"NLM": "Milki AA, Bechara M, Lew SQ, Poon AN. Chronic Kidney Disease of Non-traditional Etiology in a Young Man From Central America: Geography, Poverty, and Uncertain Pathophysiology Create a Formidable Medical Challenge Cureus. 2023 May;15(5):e38876. PMID: 37303355", "BibTeX": "@article{37303355, title={Chronic Kidney Disease of Non-traditional Etiology in a Young Man From Central America: Geography, Poverty, and Uncertain Pathophysiology Create a Formidable Medical Challenge}, author={Milki AA and Bechara M and Lew SQ and Poon AN}, journal={Cureus}, volume={15}, number={5}, pages={e38876}}"}}, {"_id": "40642858", "pmid": 40642858, "title": "Navigating Fabry Disease in a Military Aviator.", "journal": "Aerosp Med Hum Perform", "authors": ["Carlock T", "Kincaid-Sharp E", "Orsello C", "Ford AW", "El-Khoury BB"], "date": "2025-06-01T00:00:00Z", "doi": "10.3357/AMHP.6632.2025", "meta_date_publication": "2025 Jun", "meta_volume": "96", "meta_issue": "6", "meta_pages": "525-529", "score": 50228.816, "text_hl": "Initial evaluations revealed @<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@proteinuric kidney disease@@@ and an otherwise normal neurological workup indicating early @DISEASE_Fabry_Disease @DISEASE_MESH:D000795 @@@FD@@@, prompting initiation of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, @CHEMICAL_Clopidogrel @CHEMICAL_MESH:D000077144 @@@clopidogrel@@@ for @DISEASE_Stroke @DISEASE_MESH:D020521 @@@stroke@@@ prevention, and the newly Food and Drug Administration-approved chaperone therapy @CHEMICAL_migalastat @CHEMICAL_MESH:C090092 @@@migalastat@@@. ", "citations": {"NLM": "Carlock T, Kincaid-Sharp E, Orsello C, Ford AW, El-Khoury BB. Navigating Fabry Disease in a Military Aviator. Aerosp Med Hum Perform. 2025 Jun;96(6):525-529. PMID: 40642858", "BibTeX": "@article{40642858, title={Navigating Fabry Disease in a Military Aviator.}, author={Carlock T and Kincaid-Sharp E and Orsello C and Ford AW and El-Khoury BB}, journal={Aerosp Med Hum Perform}, volume={96}, number={6}, pages={525-529}}"}}, {"_id": "2442556", "pmid": 2442556, "title": "Lisinopril in hypertension associated with renal impairment.", "journal": "J Cardiovasc Pharmacol", "authors": ["Donohoe JF", "Laher M", "Doyle GD", "Cooper WD"], "date": "1987-01-01T00:00:00Z", "doi": "10.1097/00005344-198700003-00016", "meta_date_publication": "1987", "meta_volume": "9 Suppl 3", "meta_issue": "", "meta_pages": "S66-8", "score": 50082.074, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ associated with @<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@renal impairment@@@.", "citations": {"NLM": "Donohoe JF, Laher M, Doyle GD, Cooper WD. Lisinopril in hypertension associated with renal impairment. J Cardiovasc Pharmacol. 1987;9 Suppl 3():S66-8. PMID: 2442556", "BibTeX": "@article{2442556, title={Lisinopril in hypertension associated with renal impairment.}, author={Donohoe JF and Laher M and Doyle GD and Cooper WD}, journal={J Cardiovasc Pharmacol}, volume={9 Suppl 3}, pages={S66-8}}"}}, {"_id": "2161083", "pmid": 2161083, "title": "Lisinopril in hypertensive patients with renal function impairment.", "journal": "Nephron", "authors": ["de Jong PE", "Apperloo AJ", "Heeg JE", "de Zeeuw D"], "date": "1990-01-01T00:00:00Z", "doi": "10.1159/000186034", "meta_date_publication": "1990", "meta_volume": "55 Suppl 1", "meta_issue": "", "meta_pages": "43-8", "score": 50077.418, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@renal function impairment@@@.", "citations": {"NLM": "de Jong PE, Apperloo AJ, Heeg JE, de Zeeuw D. Lisinopril in hypertensive patients with renal function impairment. Nephron. 1990;55 Suppl 1():43-8. PMID: 2161083", "BibTeX": "@article{2161083, title={Lisinopril in hypertensive patients with renal function impairment.}, author={de Jong PE and Apperloo AJ and Heeg JE and de Zeeuw D}, journal={Nephron}, volume={55 Suppl 1}, pages={43-8}}"}}, {"_id": "2844084", "pmid": 2844084, "title": "Lisinopril in the treatment of hypertensive patients with renal impairment.", "journal": "Am J Med", "authors": ["Donohoe JF", "Kelly J", "Laher MS", "Doyle GD"], "date": "1988-09-23T00:00:00Z", "doi": "10.1016/0002-9343(88)90347-6", "meta_date_publication": "1988 Sep 23", "meta_volume": "85", "meta_issue": "3B", "meta_pages": "31-4", "score": 50076.566, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ in the treatment of @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@renal impairment@@@.", "citations": {"NLM": "Donohoe JF, Kelly J, Laher MS, Doyle GD. Lisinopril in the treatment of hypertensive patients with renal impairment. Am J Med. 1988 Sep 23;85(3B):31-4. PMID: 2844084", "BibTeX": "@article{2844084, title={Lisinopril in the treatment of hypertensive patients with renal impairment.}, author={Donohoe JF and Kelly J and Laher MS and Doyle GD}, journal={Am J Med}, volume={85}, number={3B}, pages={31-4}}"}}]}